top of page


European Commission approves Amneal's Adcomfo omalizumab biosimilar to Xolair
Amneal has received European Commission approval for Adcomfo, an omalizumab biosimilar to Xolair, covering several allergic and inflammatory conditions and expanding competition in the European biologics market.

nuaxia
4 days ago1 min read


Alvotech and LOTTE Biologics sign US manufacturing partnership for multiple biosimilars
Alvotech and LOTTE Biologics have entered a US manufacturing agreement covering multiple antibody biosimilars for global supply.

nuaxia
Oct 71 min read
bottom of page